Financial results for Q4 and FY 2024 released: Solid end to the year resulting in full-year results in line with latest outlook
The Group continued to grow revenue organically and deliver profit margin in line with the updated outlook for the year.
Categories: it for life sciences
Pia Bundgaard Ingels heads up NNIT Europe Region as we continue our growth journey
NNIT continues its commitment to focus on bringing digital transformation solutions to life sciences internationally. Regional execution of this strategy remains key, and Pia Bundgaard Ingels is now heading up NNIT’s activities in Europe.
Financial results for Q3 2024 released: A Challenging Third Quarter
A Challenging Third Quarter. Necessary Actions Taken to Improve Performance in 2024 and Long-term
NNIT Joins Veeva AI Partner Program
We are delighted to announce that NNIT is a Veeva AI Partner, joining a group of select global partners.
Welcome to NNIT’s New Space in Krakow, Poland
NNIT relocated to a new office space in Krakow, Poland, on September 1, and a grand opening was held on September 12.
Financial results for Q2 2024 released
Solid organic growth of 11%, profitability continued to improve, and important strategic milestones reached.
SL Controls Merges with NNIT
The integration of NNIT Group Company SL Controls was initiated in May, and plans are in place for completion by year-end 2024.
NNIT in Czech Republic Relocates to vibrant Smíchov City in Prague
On June 1, NNIT in Czech Republic relocated to the Na Knizeci Office situated on the left bank of the Vltava River in Smíchov City, Prague.
NNIT in Switzerland Relocates to New Modern Office in the Center of Basel
After more than 14 years at the same location in Switzerland, NNIT has relocated to Grosspeter Tower, an impressive 21-storey structure in the city of Basel.
Digital Transformation is key to Growth in a Challenged European Life Sciences Market
The life sciences market in Europe is idling – even hesitant – following the macro-economic and geo-political hits of war, energy crisis, inflation, increasing interest rates and increasing EU regulation. But Ricco Larsen, Senior Vice President of Life Sciences Europe at NNIT, remains positive based on a firm belief in the resilience of the industry.
Financial results for Q1 2024 released
Revenue growth of 12.2%, an operating profit margin of 5.2% – and full-year financial outlook maintained.
NNIT Releases the Valiance TRUseries 5.0 – Revolutionizing Data Migration with AI and Enhanced Performance Features
NNIT’s Migration Powerhouse, renowned for its expertise in critical data migrations where compliance and accuracy are paramount, is proud to announce the launch of the latest iteration of its flagship software, Valiance TRUseries 5.0.
NNIT reinforces AI focus and investments by anchoring regional business units in new global structure led by Director Sam Laermans
A new global structure dedicated to AI and led by Director Sam Laermans has been created to ensure unity, best practice, and maximum utilization of expertise and resources across our four regional AI business units.
The NNIT China head office relocates to support our development in the region
Our China head office has relocated from Tianjin Jinwan Mansion to Tianjin Luneng International Center to provide employees with a more convenient and flexible office environment as well as better surroundings for the collaboration with our customers and partners.
NNIT’s Marina Prodan selected as Talent 100
More than 400 talented and ambitious young people were nominated for this year's Talent 100 published by Berlingske. Only 100 talents were ultimately selected for this year’s list, and Marina Prodan is one of them.
NNIT Facilitates Seamless Transition to New Electronic Data Capture Platform for Top 20 Biopharma Pioneer
NNIT completes successful collaboration with a Top 20 Biopharma pioneer in transitioning to a new Electronic Data Capture (EDC) platform for their clinical trials.
AI transforms life sciences as we know it, yet human validation remains vital – for now
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
Financial results for Q4 and FY 2023 released: Improved business and financial performance
The Group improved business and financial performance throughout the year and delivered on the outlook, which was upgraded in August, 2023.
Life sciences needs a solid data foundation to weather the era of uncertainty
Like the rest of the world, the life sciences industry is right in the eye of a raging storm of multiple rapid changes. According to Ricco Larsen, Senior Vice President at NNIT, the top priority for pharma companies is to invest in a solid data foundation so they are fully prepared for what comes next.
Data Enablement: Leverage eTMF for business transformation
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
Show more
Loading...